Charles River Laboratories (CRL) Tops Q3 EPS by 5c; Narrows Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. NVT
8. SPY
9. AAPL
10. LITE

Go back to Charles River Laboratories (CRL) Tops Q3 EPS by 5c; Narrows Outlook

Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations

November 2, 2016 7:01 AM EDT

Third-Quarter Revenue of $425.7 Million

Third-Quarter GAAP Earnings per Share of $0.78

and Non-GAAP Earnings per Share of $1.18

Updates 2016 Guidance

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2016. For the quarter, revenue from continuing operations was $425.7 million, an increase of 21.8% from $349.5 million in the third quarter of 2015. Foreign currency translation reduced reported revenue growth by 1.5%. Revenue growth was driven primarily by the Discovery and Safety Assessment and Manufacturing Support segments.... More